FIGURE 24-21 RTK/RAS/MAP kinase pathway components are frequently mutated in cancer. Components of the RTK/RAS/MAP kinase pathway in which oncogenic mutations have been identified in human cancers are highlighted in green. Components that have been found mutated to cause inactivation of the gene in cancer cells are highlighted in red.